
Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc.(CYCC)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cycc · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2025年11月25日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$1.00
Consensus
$1.00
-80.6% upside
Low
$1.00
Median: $1 · Last Close: $5.16
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $5.16 | ↓ 0.06% |
1-day model range: $5.11–$5.21. Peak: $5.21 (-0.06%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CYCC · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-05-03 | Roth MKM | Maintains | Buy→Buy |
| 2023-12-19 | Brookline Capital | Downgrade ↓ | Buy→Hold |
| 2023-12-19 | Roth MKM | Maintains | Buy→Buy |
| 2023-05-24 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-03-06 | Oppenheimer | Maintains | Outperform→Outperform |
| 2021-04-30 | Oppenheimer | Maintains | Outperform→Outperform |
| 2020-11-25 | JMP Securities | Downgrade ↓ | Market Outperform→Perform |
| 2020-11-25 | H.C. Wainwright | Maintains | Buy→Buy |
| 2020-11-25 | Roth Capital | Maintains | Buy→Buy |
| 2018-09-05 | Roth Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Cyclacel Pharmaceuticals, Inc. (CYCC) stock. Of the recent 15 rating actions, 0 were upgrades and 4 were downgrades. 7 analysts currently cover CYCC.
分析师推荐趋势
CYCC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$0M
↓ 47.0% YoY
Revenue Next Year
$0M
↑ 88.7% YoY
EPS This Year
$-468.00
EPS Next Year
$-283.20
↓ 39.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CYCC EPS of $-468.00 for the current fiscal year, based on estimates from 1 analysts. The CYCC revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CYCC 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CYCC 的共识目标价为 $1.00(-80.6% 上行空间),分析师共识为 Buy。
CYCC 的短期预测(明日)为 $5.16(-0.06%)。
Cyclacel Pharmaceuticals, Inc. 在 NASDAQ 上市,代码 CYCC。CYCC 在 2027 年的整体展望偏积极,在覆盖分析师中约 71% 对应 Buy 共识。
常见问题
CYCC 预测 · 8 个问题根据 7 位华尔街分析师,CYCC 的 12 个月平均目标价为 $1.00,最高 $1.00、最低 $1.00。若有图表,中位目标价可在上方查看。相对当前价 $5.16,隐含约 -80.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.